News & Media

The Foundry Press

For the most current news on The Foundry, please visit The Foundry’s LinkedIn page.
For the most current news on The Foundry’s portfolio companies, please visit the companies’ websites

Sep 15, 2021
Allay Therapeutics Completes Oversubscribed $60M Financing to Advance Ultra-Sustained Pain Platform
Financing led by Arboretum Ventures. ATX-101 to advance to Phase 2b development in total knee replacement surgeries in 2021.
May 13, 2021
Allay Therapeutics Launches with First Clinical Data to Demonstrate Weeks of Pain Relief with Ultra-Sustained Non-Opioid Platform
First clinical data to demonstrate non-opioid pain relief lasting two weeks. Significant reductions in pain and opioid usage relative to standard of care. Proprietary technology platform expanding to deliver a new category of ultra-sustained localized pain products for diverse conditions
Jan 11, 2021
The Foundry Announces Successful First-in-Human Procedure in Study of Innovative Transcatheter Mitral Valve Repair Technology
Novel Technology Brings Potential to Help Millions of Patients with Mitral Valve Regurgitation
Oct 14, 2020
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology
Half Moon Medical's Technology Now Ready for Evaluation in Early Feasibility Study